Dr. Michael Brodsky

Michael Brodsky, MD, is a board-certified hematologist-oncologist with a clinical and research interest in breast cancer. He has extensive experience caring for medically complex and socioeconomically diverse patient populations and is focused on utilizing the latest advances in oncology to improve patient care, particularly in the management of chronic complications related to breast cancer treatment.

Dr. Brodsky earned a Bachelor of Arts in History and International Studies from Northwestern University and completed a post-baccalaureate premedical program at Mount Holyoke College before receiving his Doctor of Medicine from SUNY Downstate College of Medicine. He completed his Internal Medicine Residency and Hematology and Medical Oncology Fellowship at Montefiore Medical Center, Albert Einstein College of Medicine.

Dr. Brodsky has participated in clinical research focused on breast cancer, chemotherapy-induced peripheral neuropathy, pancreatic cancer, and hematologic disorders. His work includes helping launch a phase II clinical trial investigating a novel agent to prevent taxane-induced peripheral neuropathy in patients with breast cancer, as well as authoring and co-authoring multiple research publications and presentations. He remains committed to advancing breast cancer research while providing high-quality, evidence-based care to patients with cancer and blood disorders.